Table 2.

Changes in the variables during 2-week beta-congllycinin and placebo intakes

	Beta-conglycinin group (n = 8)									Placebo (n = 6)									P
	Pre			Post			⊿			Pre			Post			⊿
Age (year)	20.9	±	1.2							21.3	±	0.7
Height (cm)	168.9	±	4.7							176.3	±	3.7
Weight (kg)	59.8	±	7.0	59.9	±	6.8	0.2	±	1.0	62.0	±	6.3	62.7	±	6.3	0.8	±	1.1	0.337
BMI (kg/m²)	20.9	±	2.3	21.0	±	2.3	0.1	±	0.3	20.0	±	1.7	20.1	±	1.6	0.0	±	0.3	0.769
Body fat (%)	14.1	±	4.6	14.3	±	5.0	0.3	±	1.4	11.6	±	5.2	11.9	±	5.2	0.3	±	1.1	0.906
Serum metabolic parameters
Glucose (mg/dL)	88.9	±	2.3	90.5	±	4.8	1.6	±	4.2	93.8	±	5.8	89.5	±	8.4	-4.3	±	6.8	0.071
Triglyceride (mg/dL)	52.3	±	23.4	69.8	±	23.5	17.5	±	23.5	52.2	±	25.7	65.0	±	29.9	12.8	±	25.3	0.738
AST (U/I)	20.4	±	2.9	20.6	±	2.9	0.3	±	2.9	20.0	±	2.4	19.8	±	1.8	-0.2	±	1.3	0.762
ALT (U/I)	21.4	±	16.2	16.1	±	3.5	-5.3	±	13.9	17.3	±	6.7	17.7	±	5.1	0.3	±	2.3	0.383
FGF21 (pg/mL)	146.6	±	85.0	158.1	±	91.6	11.4	±	85.1	68.0	±	29.4	84.0	±	52.2	16.1	±	53.3	0.913
Energy and nutrients intake (/day)
Energy (kcal)	2144	±	599	2137	±	465	-7	±	285	1899	±	220	2303	±	409	404	±	671	0.147
Protein (g)	67.1	±	20.1	89.4	±	16.9	22.3	±	17.7	70.2	±	11.6	78.7	±	11.5	8.5	±	16.6	0.182
Fat (g)	74.2	±	21.5	66.9	±	17.7	-7.2	±	14.1	66.7	±	7.6	86.0	±	24.8	19.2	±	34.6	0.075
Carbohydrate (g)	279.5	±	86.4	280.7	±	63.2	1.2	±	45.2	243.6	±	33.4	285.3	±	44.2	41.8	±	78.6	0.253
BAT activity (supraclavicular - chest skin temperature; °C)
1-h after cold exposure	0.89	±	0.28	0.86	±	0.34	-0.03	±	0.24	0.90	±	0.34	0.84	±	0.35	-0.08	±	0.13	0.656
2-h after cold exposure	0.87	±	0.31	0.91	±	0.38	0.04	±	0.28	0.77	±	0.37	0.88	±	0.39	0.08	±	0.23	0.804

BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; FGF21, fibroblast growth factor 21; BAT, brown adipose tissue. Values are presented as mean ± SD. P values were obtained by unpaired Student's t test